The Product Mix Trap: How One Decision Moved Suja's Gross Margin 8 Points
Jeff Church reveals how killing 12% margin kombucha for 60% margin wellness shots moved Suja's gross margin from 32% to 40% and saved the company.

It was the summer of 2018. Coca-Cola had just called to say they weren't moving forward with buying the rest of Suja. I walked downstairs after that call and wept in front of my boys.
Then I went back upstairs and stared at our product portfolio.
We had juice. We had wellness shots. And we had kombucha... which we had launched because everyone in the natural channel was launching kombucha. GT's was everywhere. Health-Ade was everywhere. Consumers were obsessed with it. So we made a move.
And it was one of the most quietly expensive mistakes I'd made in years.
Not because kombucha was a bad product. It was technically great. We'd actually solved a really hard problem in the category — keeping alcohol levels consistent, which most brands struggled with. But there were two things I had ignored. The first was that consumers didn't see Suja as a kombucha brand. The second was the margin.
Kombucha, outsourced to a co-manufacturer: roughly 12% gross margin.
Wellness shots, produced internally: roughly 60%.
Both were on the shelf. Both were selling. But one was quietly bleeding us, and one was quietly making us.
That's the product mix trap. Your P&L looks okay... until you actually pull it apart by SKU.
The Number That Actually Matters
I've said it a hundred times and I'll say it again: "Gross margin determines destiny."
Not top-line revenue. Not door count. Not which retailers you're in.
The margin on what you're actually selling.
When you're running a portfolio of products, the blended gross margin is the number most founders look at. And it can hide a lot. It can hide the fact that your fastest-growing SKU is also your most margin-destructive one. It can hide the fact that one outsourced product is dragging the whole company's economics down. It can make you feel like you're building something healthy when you're actually subsidizing a bad bet with the profits from a good one.
This is "CPG is a penny profit business" applied at the portfolio level. It's not just that the pennies matter on a unit basis. The pennies matter on a mix basis too.
When our margins were below 32% in late 2018, I thought we had a cost problem. We had a mix problem.
What We Actually Did
Here's the sequence of what happened after that July 3rd phone call from Coca-Cola.
We had $40 million in secured debt coming due in October 2018. We were burning more than $10 million a year. And I sat down with Todd Fisher, our CFO, and we started pulling the business apart piece by piece.
The question wasn't "what can we cut?" The question was "what is actually working?"
When we ran the product-level analysis, the answer was clear. The wellness shots were working. Really working. We'd entered the shots category as the third player, behind VIVE and KOR. Within a year, we had captured north of 30% market share. At Costco alone, shots were doing about $2,000 per club per week... with a path to $15 million in annual revenue at broader rollout.
The shots were ours. Produced internally. 60% gross margin. Deeply aligned with the Suja identity of cold-pressed, concentrated nutrition.
Kombucha was borrowed. Outsourced. 12% gross margin. And consumers were kind but honest — Suja wasn't their kombucha brand. It was their juice brand, their shot brand.
The math was obvious once we looked at it clearly.
We cut kombucha. We doubled down on shots.
That single product mix decision moved our company-wide gross margin from roughly 32% to roughly 40%. And we went from losing $10 million in EBITDA in 2018 to generating $3 million in positive EBITDA in 2019.
One portfolio decision. Eight margin points. A $13 million EBITDA swing.
That's not a cost-cutting story. That's a product mix story.
The Three Questions Every CPG Founder Needs to Ask
I'm not telling you to cut your kombucha. I'm telling you to know what's in your kombucha.
Before you add a new SKU, before you take on a new category, before you say yes to a retailer who wants you to build them an exclusive line that's "incremental" to your business... ask three questions:
1. What is this product's gross margin, and how does it compare to my best SKU?
Not category average. Not what you think it should be. The actual number, fully loaded. If you're outsourcing it to a co-man, include freight, warehousing, slotting, and the time you're spending managing it. Most founders dramatically underestimate the true cost of a low-margin product.
If the answer is more than 15 points below your highest-margin SKU, you need a really compelling reason to carry it.
2. Do consumers believe we should make this?
This is the "brand permission" test. You've built equity in a category. Does this new product extension draw from that equity, or does it borrow against it?
Suja's wellness shots worked because they were a concentrated version of what cold-pressed juice already was. Concentrated nutrition. Health without the punishment. Consumers got it immediately.
Suja's kombucha didn't work because we weren't a fermentation brand. We were a cold-pressed brand. The consumer said "I trust Suja for juice" — and when we put kombucha in front of them, there was a small but real moment of confusion. In CPG, consumer confusion kills velocity. And low velocity kills shelf space.
"Expansion strengthens a brand when it builds on what you already do well." The inverse is also true.
3. What does this product cost me that's not on the P&L?
Complexity has a price. Every additional SKU you carry is adding pressure to your demand planning, your co-man relationships, your inventory management, your sales team's attention. The question isn't just "does this product make money." The question is "does this product make money relative to the attention it consumes."
The most insidious low-margin SKUs are the ones that are big enough to require serious management time but small enough that you feel guilty about cutting them. Those are the ones that quietly drain you.
How to Run Your Own Mix Analysis
Here's the practical version. Block two hours with your CFO or head of ops and do this:
Pull every SKU. Calculate the actual gross margin on each one — net revenue minus COGS, fully loaded. Include any variable production or co-packing costs, freight to retailer, and a rough allocation for trade spend if you can.
Rank them from highest to lowest margin. Then rank them by revenue contribution. Then rank them by velocity.
Now look for the disconnects.
High revenue, low margin, declining velocity? That's a problem product masquerading as a strong one.
Low revenue, high margin, growing velocity? That's your rocket. Feed it.
Low revenue, low margin, flat velocity? Cut it. You're paying to carry it.
The goal is not to have the most products. The goal is to have the right products. At Suja, we launched 275 SKUs in our first seven years — that's roughly one new SKU every nine days. We aggressively discontinued all but 55. Of the original top-10 SKUs, only one was still in the top 10 a decade later.
"Revenue without margin is ego."
Every SKU you're carrying that isn't earning its place is a vote against your own future.
One More Thing About the Fortune Teller
In 2014, my wife Linda visited a fortune teller named Tara. Tara told her the product creating the most value for Suja would be wellness shots.
At the time, our co-founder Bryan had just begun experimenting with early formulations. We all thought it was a fun little prediction.
Four years later, sitting with $40M in debt and Coca-Cola's no still ringing in my ears, it was the wellness shots that were actually there for us.
I'm not suggesting you take strategic direction from psychics. I'm suggesting that sometimes the answer to "what do we really have" has been in front of you longer than you realized. You just had to get honest enough to look.
That's what the product mix trap costs you most. Not margin points. Time.
Every month you carry a low-margin, low-velocity product that doesn't belong in your portfolio is a month you're not fully funding the one that does.
"Dream boldly. Plan soberly."
Run the analysis. Make the call.
If you're wrestling with your product portfolio or trying to build financial discipline into your brand's strategy, the CPG MBA program is where we go deep on these decisions — with real numbers, real case studies, and the frameworks that actually move the needle. And if your brand needs a structured 90-day push to sharpen execution and unlock growth, check out the 90-Day Breakthrough program. Both are built for founders who are serious about building something that lasts.
Want more insights like this?
Get Jeff’s take on what’s actually working in CPG. Direct to your inbox.